TG Therapeutics | TGTX - Trade Debtors


TG Therapeutics reported $265.38M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Amgen USD 9.57B 1.08B Dec/2025
Ardelyx USD 71.85M 4.76M Dec/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Bayer EUR 14.19B 720M Dec/2025
Biogen USD 1.85B 234M Sep/2025
Corcept Therapeutics USD 59.79M 9.84M Dec/2025
Curis USD 2.55M 400K Jun/2024
Gilead Sciences USD 4.91B 182M Dec/2025
J&J USD 17.61B 235M Sep/2025
Karyopharm Therapeutics USD 31.78M 6.82M Sep/2024
Novartis USD 12.29B 3.3B Dec/2025
Novavax USD 106.45M 72.27M Dec/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025
Verastem USD 200K 10.72M Sep/2024
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025